EU approves AstraZeneca Covid-19 vaccine
29th Jan 2021 16:41
(Sharecast News) - The European Union drug regulator said on Friday that it has approved the use of AstraZeneca's Covid-19 for use in adults.
Read moreModerna cuts vaccine deliveries to Italy and France
29th Jan 2021 10:41
(Sharecast News) - Moderna has told Italy and France they will get fewer vaccine doses than expected in February in a further setback for EU vaccination programmes, according to a report.
Read moreEU drug watchdog reviewing Astra/Oxford Covid vaccine application
12th Jan 2021 09:00
(Sharecast News) - The EU's drugs regulator said it would review a conditional approval application for AstraZeneca and Oxford University's Covid-19 vaccine this month under an accelerated timeline.
Read moreAstraZeneca's Farxiga gets Priority Review status in the US
6th Jan 2021 07:35
(Sharecast News) - AstraZeneca announced on Wednesday that 'Farxiga', or dapagliflozin, has been granted Priority Review status in the United States for the treatment of new or worsening chronic kidney disease (CKD) in adults with and without type-2 diabetes (T2D).
Read moreFDA warns against reducing Covid-19 vaccine doses
5th Jan 2021 12:22
(Sharecast News) - Reducing the dosage of currently approved Covid-19 vaccines could pose a public health risk, the Food and Drug Administration said.
Read moreChina's Sinopharm seeks Covid vaccine approval at 79% effectiveness
30th Dec 2020 11:51
(Sharecast News) - Chinese Covid-19 vaccine developer Sinopharm said it will seek approval from regulators after final stage trials showed a 79% efficacy rate.
Read moreUK approves Oxford University/AstraZeneca Covid-19 vaccine
30th Dec 2020 07:38
(Sharecast News) - The Oxford University/AstraZeneca Covid-19 vaccine has been approved for use in the UK, with vaccinations set to begin early in the New Year.
Read moreAstraZeneca's Lynparza cancer drug approved by Japan
29th Dec 2020 07:02
(Sharecast News) - AstraZeneca and Merck's Lynparza has been approved in Japan for the treatment of advanced ovarian, prostate and pancreatic cancers, the UK-based pharmaceutical company said on Tuesday.
Read moreSunday newspaper round-up: AstraZeneca, Boxing Day, Britain's economy
27th Dec 2020 12:39
(Sharecast News) - The chief executive of AstraZeneca has raised hopes its vaccine with Oxford is more effective than first thought amid the rapid spread of the new UK virus strain across the globe. Pascal Soriot said he believed researchers had found the "winning formula" using two doses and promised to publish the results as reports suggested the UK regulator could approve the jab within days. - Sunday Telegraph
Read moreAstraZeneca issues updates on roxadustat and Tagrisso
21st Dec 2020 08:03
(Sharecast News) - Pharmaceutical giant AstraZeneca issued updates on both roxadustat and Tagrisso on Monday, with one drug facing a delay to its application and the other being granted approval in the US.
Read moreThursday broker round-up
17th Dec 2020 13:13
(Sharecast News) - Yellow Cake: Berenberg reiterates buy with a target price of 300p.
Read moreS&P places AstraZeneca's debt on Credit Watch Positive on proposed purchase of Alexion
16th Dec 2020 14:34
(Sharecast News) - Standard&Poor's placed its rating on AstraZeneca's long-term corporate debt on so-called Credit Watch Positive following news of its intended purchase of US rare disease specialist Alexion.
Read moreAstraZeneca gets recommendation for new Imfinzi dosing option
15th Dec 2020 07:17
(Sharecast News) - AstraZeneca announced on Tuesday that 'Imfinzi', or durvalumab, had been recommended for marketing authorisation in the European Union for an additional dosing option.
Read moreSector movers: AstraZeneca leads Big Pharma lower
14th Dec 2020 19:09
(Sharecast News) - Pharmaceuticals paced decliners on Monday as markets reacted poorly to the news of a $39bn cash and shares takeover offer for rare diseases specialist Alexion from the UK's AstraZeneca.
Read moreMonday broker round-up
14th Dec 2020 13:32
(Sharecast News) - Midwich Group: Berenberg reiterates buy with a target price of 550p.
Read more